We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Capsaicin Shown to Be Potent Anticancer Agent

By Biotechdaily staff writers
Posted on 20 Apr 2006
The hot ingredient in red chili pepper, called capsaicin, has cancer-fighting properties that prevent or slow the growth of pancreatic cancer tumors implanted in mice, according to a new study.

Researchers at the University of Pittsburgh School of Medicine (PA, USA) found that capsaicin fed orally to mice with human pancreatic tumors caused the cancer cells to die through apoptosis. Their findings were presented at the annual meeting of the American Association for Cancer Research in Washington (DC, USA) in April 2006.

Lead investigator Dr. Sanjay K. Srivastava, Ph.D., and colleagues fed mice grafted with human pancreatic tumors different amounts of capsaicin for five days per week or three days per week, according to their weight, then compared tumor size and levels of apoptotic proteins in the tumors to those in a control group of mice that received normal saline only. They found that the mice that received the capsaicin had increased levels of proteins associated with apoptosis and significantly smaller tumors sizes than the control group. Tumors treated with capsaicin were half the size of tumors in nontreated mice. Further testing revealed that capsaicin disrupted the mitochondrial function, which resulted in the release of several apoptotic proteins but it did not negatively affect normal pancreatic cells.

"Our results demonstrate that capsaicin is a potent anticancer agent, induces apoptosis in cancer cells and produces no significant damage to normal pancreatic cells, indicating its potential use as a novel agent for the prevention and treatment of pancreatic cancer,” said Dr. Srivastava.



Related Links:
U. of Pittsburgh

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
20 Apr 2006  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
20 Apr 2006  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
20 Apr 2006  |   BioResearch